Comparison of Liver Histopathology with Non-invasive Inflammation Markers as Neutrophil-lymphocyte Ratio, Platelet-lymphocyte Ratio and Mean Platelet Volume in Chronic Hepatitis B Patients
Journal Title: Viral Hepatitis Journal - Year 2021, Vol 27, Issue 1
Abstract
Objectives: Platelet-lymphocyte ratio (PLR) and neutrophillymphocyte ratio (NLR) are commonly studied non-invasive inflammatory markers in cancer patients. There are some studies showing its association with fibrosis in patients with non-alcoholic steatohepatitis and chronic hepatitis B (CHB). The aim of this study is to examine the relationship between liver histopathology and viral load parameters with NLR, PLR and mean platelet volume (MPV) in patients with CHB. Materials and Methods: Two hundred twenty-four CHB patients who admitted to our clinic between 2016 and 2019 and underwent liver biopsy were analysed retrospectively. Study data were obtained from patient files and electronic records. Results: The mean values in complete blood count were MPV: 10.39±1.114 fL, NLR: 2.093±1.048 and PLR: 106.228±37.451. The mean fibrosis score in liver biopsies was 1.38±1.07 and the histological activity index (HAI) was 5.88±2.27. There was a statistical significant relationship between MPV and fibrosis (r=0.244, p=0.005), HBV-DNA and HAI (r=0.296, p=0.001), HBV-DNA and fibrosis (r=0.278, p=0.001) in men. There was no statistical significant difference between the genders in terms of fibrosis scores and inflammatory parameters. Non-invasive markers didn’t make a statistical significant difference according to HAI <6 and HAI ≥6, fibrosis <2 and fibrosis ≥2 and HBV-DNA <20,000 and HBV-DNA ≥20,000 (p>0.05). Conclusion: It has been determined that MPV may be a useful marker for predicting fibrosis in patients with CHB, but further studies are needed to replace liver biopsy. Continuous monitoring of MPV will contribute to disease surveillance. NLR and PLR weren’t found to be an important marker for evaluating fibrosis.
Authors and Affiliations
Hakan Demiröz, Mehmet Bayram, Kader Irak, Özgür Yıldırım, Abdulbaki Kumbasar, Ömür Tabak
Keywords
Related Articles
- EP ID EP694432
- DOI 10.4274/vhd.galenos.2021.2020-11-3
- Views 72
- Downloads 0
HBV Flare Under Tenofovir Treatment in Chronic Hepatitis B: Case Report
The purpose of chronic hepatitis B treatment is to stop the progression of the disease and prevent cirrhosis and liver cancer that may occur with the progression of the disease. In the current treatment, one of the nucle...
Frequency of Hepatitis Delta Virus in Hepatitis B Surfaceantigen-positive Patients
Objectives: The prevalence of hepatitis delta virus (HDV) worldwide shows geographical differences. Although there are several studies on anti-HDV seroprevalence rates in hepatitis B surface antigen (HBsAg)-positive pati...
The Long-term (10.6 years) Outcome of Hepatitis C patients with Sustained Virologic Response Following Treatment with Pegylated Interferon + Ribavirin
Objectives: Directly-acting anti-viral agents for the treatment of hepatitis C have been revolutionised. In the meantime, hepatitis C patients with sustained virologic response (SVR) achieved with previous treatments hav...
Evaluation of Hepatitis C Virus Genotype Results in İzmir Atatürk Training and Research Hospital
Objectives: The aim was to support both the clinical treatment and management and also to contribute to the epidemiological understanding of the hepatitis C virüs (HCV) genotype in our region. Materials and Methods: HCV...
Evaluation of Signal/Cut-off Ratio by Anti-hepatitis Delta Virus Enzyme Immunoassay Method in the Diagnosis of Hepatitis Delta Virus Infection
Objectives: The hepatitis delta virus (HDV) is an enveloped, negative-sense, single-stranded RNA virus in the genus Deltavirus. In this study, it was aimed to evaluate the ratio of anti-HDV signal/ cut-off (S/CO) in the...